Return Accountability

Xerimis is able to receive used and unused clinical supplies at study end for the performance of accountability and destruction. Depending on the supplies, Xerimis is able to perform accountability to the level requested by the client (i.e. confirm that kits are tamper sealed, count bottles or tablets). Our Returns Coordinator would be your primary contact for this procedure, ensuring that the accountability process and reports are completed in the format that fits your study needs. Once accountability is complete and pending client authorization, the returned drug product would be destroyed by a vendor qualified by Xerimis. Xerimis is capable of coordinating destruction for hazardous and non-hazardous supplies.